首页> 外文会议>International conference on computational science and its applications >Detection and Classification of Hippocampal Structural Changes in MR Images as a Biomarker for Alzheimer's Disease
【24h】

Detection and Classification of Hippocampal Structural Changes in MR Images as a Biomarker for Alzheimer's Disease

机译:MR图像中海马结构变化的检测和分类,作为阿尔茨海默氏病的生物标记

获取原文

摘要

Alzheimer's disease (AD) is the most common form of dementia, comprising around 60% of all dementia cases and affecting 20% of the population over 80 years of age. AD may affect people in different ways. The most common symptom pattern begins with a gradually worsening ability to remember new information, difficulty to solve problems and perform familiar tasks at home, confusion about time or place, and trouble understanding visual images. Currently, the volume reduction of the two hippocampi is the most used structural magnetic resonance imaging (MRI) biomarker of AD. However, despite its clinical use, hippocampal volume reduction is involved not only in AD but also in other dementias and even in healthy aging. In this study, we propose a new computational framework for the detection and classification of hippocampal structural changes in MR images as a biomarker for AD. First, we built a probabilistic atlas of 3D salient points using a dataset of healthy brain images. Then, we detected 3D salient points in a training dataset with cognitively normal (CN) and mild-AD brain images and used them to label each point on the atlas. Next, the 3D salient points detected in each image from the training dataset were matched against the labeled points in the atlas, and their descriptor vectors were used to train a support vector machine with radial basis function (SVM-RBF). Last, we detected 3D salient points, extracted their descriptor vectors, matched them against the atlas and classified them using the SVM-RBF classifier, for each image from the testing dataset. Finally, we attribute a class label (CN/mild-AD) according to the majority of points classified in the corresponding class. We tested our proposed framework using a stratified age group image dataset (551 MR images in total) and assessed the results using a 10-fold cross-validation and ROC methodology. The highest accuracy value achieved by our method was 85% (up to 82.59% sensitivity and 88.50% specificity) for the age group 70-89, and the highest area under the curve was 0.9227.
机译:阿尔茨海默氏病(AD)是痴呆症的最常见形式,占所有痴呆症病例的60%左右,并影响80岁以上人口的20%。 AD可能以不同的方式影响人们。最常见的症状模式是记忆能力逐渐下降,开始记住新信息,难以解决问题和在家中执行熟悉的任务,对时间或地点的困惑以及对视觉图像的理解变得困难。当前,减少两个海马体的体积是AD最常用的结构磁共振成像(MRI)生物标志物。然而,尽管其临床应用,海马体积减少不仅与AD有关,而且与其他痴呆症甚至健康衰老有关。在这项研究中,我们提出了一个新的计算框架,用于检测和分类MR图像中的海马结构变化,作为AD的生物标记。首先,我们使用健康的大脑图像数据集构建了一个3D显着点概率图集。然后,我们在具有认知正常(CN)和轻度AD脑图像的训练数据集中检测到3D显着点,并使用它们在图集上标记每个点。接下来,将训练数据集中每个图像中检测到的3D显着点与地图集中的标记点进行匹配,并将它们的描述符向量用于训练具有径向基函数(SVM-RBF)的支持向量机。最后,我们针对测试数据集中的每个图像,检测了3D显着点,提取了它们的描述符矢量,将它们与图集匹配,并使用SVM-RBF分类器对其进行了分类。最后,我们根据归类到相应类别中的大多数点来归类一个类别标签(CN / mild-AD)。我们使用分层年龄组图像数据集(总共551张MR图像)测试了我们提出的框架,并使用10倍交叉验证和ROC方法评估了结果。对于70-89岁年龄段的人群,通过我们的方法获得的最高准确度值为85%(灵敏度高达82.59%,特异性达到88.50%),曲线下的最高面积为0.9227。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号